GE HealthCare Technologies Inc.
Pushing the boundaries of Neuroscience with GE HealthCare’s SIGNA MAGNUS
Lineage Cell Therapeutics Inc.
Lineage Cell Therapeutics to Report First Quarter 2024 Financial[...]
04/25/2024 | Press release | Distributed by Public on 04/25/2024 14:30
Please select the service you want to use:
Smartlinks | First Trust Energy Income and Growth Fund | First Trust Portfolios LP | Company News | Financial Services | Mutual Funds | Investment Services | Securities Issuers | Closed-End Funds | New York Stock Exchange (NYSE) | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Investors Exchange (IEX) | Nasdaq BX | Nasdaq Intermarket | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact